Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02378961
What this trial is testing

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 128
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT01057667
What this trial is testing

RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Large-scale testing (Phase 3)Study completedNCT02105701
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)

Who this might be right for
Hepatitis C Infection
Merck Sharp & Dohme LLC 420
Testing effectiveness (Phase 2)Ended earlyNCT01701063
What this trial is testing

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 42
Large-scale testing (Phase 3)Study completedNCT01674725
What this trial is testing

Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 187
Large-scale testing (Phase 3)Study completedNCT02105688
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 301
Early research (Phase 1)Study completedNCT01582035
What this trial is testing

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Who this might be right for
Hepatitis C
Janssen R&D Ireland 7
Testing effectiveness (Phase 2)Study completedNCT02569710
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 161
Testing effectiveness (Phase 2)Study completedNCT01356160
What this trial is testing

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 351
Testing effectiveness (Phase 2)Study completedNCT02536313
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 49
Early research (Phase 1)Study completedNCT01193478
What this trial is testing

A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
HCV Infection
Gilead Sciences 71
Testing effectiveness (Phase 2)Study completedNCT02716428
What this trial is testing

Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more
Trek Therapeutics, PBC 25
Early research (Phase 1)Study completedNCT00752687
What this trial is testing

ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

Who this might be right for
Hepatitis C
Abbott 100
Testing effectiveness (Phase 2)Study completedNCT00797745
What this trial is testing

A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 111
Post-approval studies (Phase 4)Study completedNCT00394277
What this trial is testing

Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,175
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Testing effectiveness (Phase 2)Study completedNCT01911845
What this trial is testing

An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine

Who this might be right for
Chronic Hepatitis C InfectionChronic Hepatitis C
AbbVie 38
Large-scale testing (Phase 3)Study completedNCT01945294
What this trial is testing

Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 257
Next Page